Keyphrases
Meningioma
100%
Tumor
38%
Histopathological Features
35%
Glioblastoma
33%
Radiotherapy
30%
Genetic Modification
29%
Central Nervous System Tumors
25%
Molecular Diagnostics
25%
Neurofibromatosis Type 1 (NF-1)
25%
Clinical Features
25%
Clinical Outcomes
24%
Overall Survival
23%
DNA Methylation (DNAm)
23%
Malignant Peripheral Nerve Sheath Tumor (MPNST)
23%
Neurofibromatosis Type I
23%
Preoperative Patients
20%
Genetic Events
20%
Metagenomic Next-generation Sequencing (mNGS)
20%
Brain Tumor Patients
20%
Physical Health-related Quality of Life
20%
Short-term Postoperative Outcomes
20%
Glioma
20%
IDH-mutant Glioma
20%
Molecular Characterization
20%
SOX10
20%
IDH-wildtype
17%
Immunoreactivity
16%
Single Institution
15%
Next-generation Sequencing
15%
Isocitrate Dehydrogenase 1 (IDH1)
14%
Treatment Resistance
14%
Resection
14%
Ganglioglioma
14%
Target Gene Expression
13%
Molecular Features
13%
Schwannoma
12%
Neuro-oncology
12%
Gliosarcoma
12%
Oligodendroglioma
12%
Histology
12%
Meningioma Recurrence
12%
Risk Score
11%
Schwann Cell Differentiation
11%
Peripheral Nerve Sheath Tumor
11%
Malignant Transformation
11%
Therapeutic Vulnerabilities
11%
DNA Methylation Profile
11%
Clinical Course
10%
Progression-free Survival
10%
Competencies
10%
Medicine and Dentistry
Neoplasm
92%
Meningioma
92%
Ganglioglioma
68%
Radiation Therapy
41%
Surgery
37%
Glioblastoma
34%
Neurofibromatosis Type I
33%
Next Generation Sequencing
30%
Diagnosis
30%
Central Nervous System Tumor
27%
Brain Tumor
24%
Biopsy
21%
Quality of Life
20%
Neurinoma
20%
Malignant Peripheral Nerve Sheath Tumor
20%
Central Nervous System
19%
Overall Survival
14%
Immunoreactivity
14%
Nerve Sheath Tumor
13%
Gene Mutation
12%
Odds Ratio
12%
Neuro-Oncology
11%
Oligodendroglioma
11%
Chemoradiotherapy
11%
Disease Course
11%
Malignant Transformation
11%
Sella turcica
10%
Transactivation
10%
Cancer Staging
10%
Hypercalcaemia
10%
Tumor Suppressor Protein
10%
Cesium 131
10%
Liver Graft
10%
Reoperation
10%
Positron Emission Tomography
10%
Partial Hepatectomy
10%
Gene Expression Profiling
10%
Magnetic Resonance Imaging
10%
Lymph Node
10%
Thymoma
10%
Lymphadenitis
10%
Skull Base
10%
Foramen Magnum
10%
Cell Dedifferentiation
10%
Neurofibromatosis
10%
Pulmonary Embolism
10%
Myositis
10%
Pleomorphic Xanthoastrocytoma
10%
Radiosurgery
10%
Indel Mutation
10%
